Mesothelioma trials in South Korea

3 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  Where

  Seoul

  Age

  18 years and over

  People

  952 worldwide

  Run by

  Genmab

  See details and how to joinNCT05579366
• Phase 2Taking people
  Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

  Where

  Incheon, Namdong-gu, Seoul

  Age

  18 years to 64 years

  People

  257 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06535607 · EU 2025-523947-36-00
• Phase 1/2Taking people
  A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  Where

  Daegu, Goyang-si, Incheon, Seoul

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04104776 · EU 2023-508002-20-00